文献速递腹部泌尿生殖CT

双能CT对偶发肾脏肿物的表征:有效原子序数图鉴别非强化囊肿与强化肿物的诊断准确性

Characterization of Incidental Renal Mass With Dual-Energy CT: Diagnostic Accuracy of Effective Atomic Number Maps for Discriminating Nonenhancing Cysts From Enhancing Masses.
PubMed 文献 · AJR Am J Roentgenol · 2017-07-13

研究评估双能对比增强数据重建的有效原子序数图鉴别非强化肾囊肿与强化肿物的诊断准确性,纳入206例患者,以常规非增强和肾图期图像为参考标准。非强化与强化肿物平均有效原子序数差异显著,阈值8.36 Zeff对应AUC 0.92、敏感度90.8%、特异度85.2%、总诊断准确性86.6%。

要点

  • 有效原子序数图可鉴别非强化肾囊肿与强化肿物,阈值8.36 Zeff对应AUC 0.92。
  • 敏感度90.8%(158/174),特异度85.2%(445/522),总诊断准确性86.6%(603/696)。
  • 非强化与强化肿物平均Zeff差异显著:合并集8.13 vs 9.37 Zeff(p < 0.0001)。

核心结论

  • 由双能对比增强CT数据生成的有效原子序数图可鉴别非强化肾囊肿(包括高密度囊肿)与强化肿物,当缺乏全面评估肾肿物的CT方案时该技术可能有临床实用性。

研究设计与样本

  • 在两个不同医院纳入206例患者(128男,78女;平均年龄64岁),行CT肾肿物方案(单能非增强和双能对比增强肾图期成像),两名盲法独立观察者在有效原子序数图上测量,以非增强和肾图期图像评估并结合影像和病历记录为参考标准。

关键影像表现/征象

  • 非强化与强化肿物平均有效原子序数差异显著:A集8.19 vs 9.59 Zeff,B集8.05 vs 9.19 Zeff,合并集8.13 vs 9.37 Zeff(p < 0.0001)。

诊断标准与关键数值

  • 有效原子序数阈值8.36 Zeff为最佳阈值,AUC 0.92(95%CI 0.89-0.94)。
  • 阈值8.36 Zeff对应敏感度90.8%(158/174,95%CI 85.5-94.7%)、特异度85.2%(445/522,95%CI 81.9-88.2%)、总诊断准确性86.6%(603/696,95%CI 83.9-89.1%)。

临床应用与阅片要点

  • 由双能对比增强CT数据生成的有效原子序数图可用于鉴别非强化肾囊肿与强化肿物。
  • 该技术可能在缺乏全面评估肾肿物的CT方案时具有临床实用性。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: The purpose of this study was to assess the diagnostic accuracy of effective atomic number maps reconstructed from dual-energy contrast-enhanced data for discriminating between nonenhancing renal cysts and enhancing masses.

MATERIALS AND METHODS: Two hundred six patients (128 men, 78 women; mean age, 64 years) underwent a CT renal mass protocol (single-energy unenhanced and dual-energy contrast-enhanced nephrographic imaging) at two different hospitals. For each set of patients, two blinded, independent observers performed measurements on effective atomic number maps from contrast-enhanced dual-energy data. Renal mass assessment on unenhanced and nephrographic images, corroborated by imaging and medical records, was the reference standard. The diagnostic accuracy of effective atomic number maps was assessed with ROC analysis.

RESULTS: Significant differences in mean effective atomic numbers (Zeff) were observed between nonenhancing and enhancing masses (set A, 8.19 vs 9.59 Zeff; set B, 8.05 vs 9.19 Zeff; sets combined, 8.13 vs 9.37 Zeff) (p < 0.0001). An effective atomic number value of 8.36 Zeff was the optimal threshold, rendering an AUC of 0.92 (95% CI, 0.89-0.94), sensitivity of 90.8% (158/174 [95% CI, 85.5-94.7%]), specificity of 85.2% (445/522 [95% CI, 81.9-88.2%]), and overall diagnostic accuracy of 86.6% (603/696 [95% CI, 83.9-89.1%]).

CONCLUSION: Nonenhancing renal cysts, including hyperattenuating cysts, can be discriminated from enhancing masses on effective atomic number maps generated from dual-energy contrast-enhanced CT data. This technique may be of clinical usefulness when a CT protocol for comprehensive assessment of renal masses is not available.

来源:AJR Am J Roentgenol,查看原文。版权归原作者所有。

引用

  1. Mileto A, Allen BC, Pietryga JA, et al. Characterization of Incidental Renal Mass With Dual-Energy CT: Diagnostic Accuracy of Effective Atomic Number Maps for Discriminating Nonenhancing Cysts From Enhancing Masses. AJR Am J Roentgenol. 2017. PMID: 28705069. doi:10.2214/AJR.16.17325

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。